Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Siplizumab, Cyclophosphamide, and Splenectomy for Preventing Liver Transplant Rejection in Patients Receiving a Deceased Donor Liver

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    Sweden
  • Long-Term Follow-Up Study of TX200-TR101 for Patients with Kidney Transplant Rejection

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium The Netherlands
  • Study Comparing Tacrolimus Formulations for Preventing Liver Transplant Rejection in New Adult Recipients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Germany
  • Study on Siplizumab and Rabbit Anti-Thymocyte Globulin for Preventing Rejection in New Kidney Transplant Patients

    Not recruiting

    2 1 1 1
    Austria Spain Sweden
  • Study on the Safety of TX200-TR101 for Preventing Kidney Transplant Rejection in Patients Receiving a Living Donor Transplant

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium The Netherlands
  • Study Comparing Tacrolimus Levels in Children with Organ Transplants Switching from Prograf to Advagraf

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Czechia
  • Study Comparing Tacrolimus Formulations for Preventing Kidney Transplant Rejection in Adults

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Germany
  • Study on Tacrolimus Dosing for Stable Adult Kidney Transplant Patients in the First Year After Transplantation

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Austria Czechia France Germany The Netherlands Spain
  • Study on Liver Transplantation: Comparing Custodiol-N Solution with a Drug Combination for Organ Preservation in Patients Undergoing Liver Transplant Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Spain